-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics Q1 EPS $(1.11) Misses $(0.94) Estimate

Benzinga·05/08/2026 12:53:38
Listen to the news
Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.94) by 19.35 percent. This is a 344 percent decrease over losses of $(0.25) per share from the same period last year.